Laboratorios Ovejero S.A is a pharmaceutical company that produces veterinary products and medicines integrated in Ovejero Group, which includes different companies related to animal health and biotechnology located in several European, American and Asian countries.
With over 70 years of experience, Laboratorios Ovejero has a wide range of veterinary products and value-added services for the health care of most animal species, which are already sold in more than 50 countries.
His commitment to research has been accentuated in recent years with the development of biotechnological products following the highest demands of safety and efficiency.
Laboratorios Ovejero is a reference in immunotherapy, an area which has last generation drugs to improve the immune system of animals, a firm commitment to preventive medicine, reducing and optimizing the use of antibiotics, and improving public health.
The laboratory begins its activities
Inauguration of the first freeze-drying plant for industrial production of vaccines + development of the first vaccine against bluetongue
Launch of the first vaccine against classic swine fever
Ovejero opens the first plant for the production of specific pathogen-free eggs (SPF). Launch of avian vaccines + launch of the vaccine against brucellosis.
Ovejero launches vaccines for the treatment of myxomatosis and Viral Haemorrhagic Disease in rabbits.
Inauguration of modern production plant under Good Manufacturing Practices (GMP) standards.
nternational expansion to Latin America (three subsidiaries), Asia (Philippines headquarters) and Europe (purchase of Biowet Drwalew Poland in 2010).
Launch of Fortinmune Bov, last generation immunomodulatory.
Launch of PIROA Lactis Tool, a Comprehensive program for the reduction and optimization of the use of antibiotics
Laboratorios Ovejero has the mission of offering veterinarians effective and profitable solutions for the care and prevention of animal health, in order to contribute to their well-being and that of people.
Through a careful R & D & I policy, Laboratorios Ovejero develops products and services that optimize animal health, generating added value in the agri-food chain, in terms of quality assurance and firmly betting on food safety and sustainability.
Laboratorios Ovejero, a comprehensive vision of health aligned with One Health
Under the umbrella of the One Health movement, the laboratory markets its products in more than 50 countries, betting on leadership in areas such as immunology, in line with global demands that advocate the development of alternative therapies to the use of antibiotics to avoid resistance that put human and animal health at risk.
Our management team
Juan Pablo Ovejero
José Ángel Rodríguez
Head of Records
Responsible for CIDSA
Responsible for I+D+i
Director of International Business
Director of operations
Responsible for Biosecurity and Immunotherapy
Jose María Alonso
Head of HR
José Ramón García
Head of IT
Juan Carlos Díaz
Ángel Luis Díez
Central Plant: Laboratorios Ovejero (Spain)
Laboratorios Ovejero has a modern manufacturing plant in León (Spain)
Founded in 1948, Laboratorios Ovejero made an important industrial breakthrough in the 1990s, culminating in the inauguration of a new production plant in León, which meets the strict Good Manufacturing Practices GMP.
Subsidiary: Biowet Drwalew(Poland)
Ovejero Group se refuerza con Biowet, disponiendo de una planta de producción en Drwalew (Polonia)
Founded in 1929, Biowet Drwalew becomes part of Ovejero Group since 2010, producing a wide range of veterinary medicines in Poland under strict Good Manufacturing Practices GMP.
Laboratorios Ovejero commercializes its products in more than 50 countries through its commercial subsidiaries.
Ovejero Group is present in 3 continents (Europe, America and Asia), with the 2 factories in Spain and Poland, which supply veterinary products to their customers throughout the world.
We want to help you
DO WE SPEAK?